SCHEMBL23611367

SCHEMBL23611367

FC(F)(F)c1cc(SCc2nc3cc(Oc4ccccc4)ccc3[nH]2)cc(-c2cn[nH]c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ PDE10A Q9Y233 1/20 0.37
▸ GRIN1 Q05586 5/20 0.36
▸ GRIN2B Q13224 5/20 0.36
▸ SDHB P21912 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ LOX P28300 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30062605 1.00 NPC1 (0.39) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL30060483 0.86 PRMT5 (0.37) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL21611960 0.83 NPC1 (0.43) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL21612005 0.83 RAB9A (0.43) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL21611983 0.81 PDE10A (0.48) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL31694532 0.77 SMN1; SMN2 (0.37) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL21612004 0.73 PDE10A (0.44) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL24027392 0.73 NPC1 (0.43) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL21611967 0.73 PDE10A (0.42) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL21611990 0.72 GRIN1 (0.43) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
WO-2021136805-A1 NOVEL PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 — — WO disclosed
Send feedback